Loading…

Urine drug screening on labor and delivery

Substance use including opioids, methamphetamines, benzodiazepines, and barbiturates during pregnancy is harmful for the pregnant person and the fetus. Routine screening using validated questionnaires is recommended, but often biologic sampling is done instead. There is often bias in urine drug scre...

Full description

Saved in:
Bibliographic Details
Published in:American journal of obstetrics & gynecology MFM 2022-11, Vol.4 (6), p.100733, Article 100733
Main Authors: Chin, Jennifer M., Chen, Eileen, Wright, Tricia, Bravo, Ricardo M., Nakashima, Eryn, Kiyokawa, Miki, Karasaki, Kameko, Estrada, Pamela, Ghatnekar, Reema, Lee, Men-Jean, Bartholomew, Marguerite Lisa
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Substance use including opioids, methamphetamines, benzodiazepines, and barbiturates during pregnancy is harmful for the pregnant person and the fetus. Routine screening using validated questionnaires is recommended, but often biologic sampling is done instead. There is often bias in urine drug screening on labor and delivery units. This study aimed to compare characteristics of people who did and did not receive urine drug screening during labor and delivery and to examine the relationship of maternal results to neonatal results. This was a retrospective chart review examining all people in 2017 who delivered in the labor and delivery unit at our institution. We collected urine drug screening result information, maternal demographic data, follow-up after positive maternal tests, and neonatal test results. Individual characteristics and obstetrical outcomes were analyzed. Of 6265 deliveries, 297 urine drug screening tests were ordered. People who were tested identified most commonly as Native Hawaiian or Pacific Islander (P
ISSN:2589-9333
2589-9333
DOI:10.1016/j.ajogmf.2022.100733